Amgen gives CEO a pay bump despite its eventful year ending in stagnant revenuenews2022-04-06T13:52:56+00:00April 6th, 2022|Fierce Pharma|
Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyoutnews2022-04-06T13:50:59+00:00April 6th, 2022|Fierce Pharma|
Novartis scores accelerated FDA nod for Vijoice to treat rare overgrowth conditionnews2022-04-06T13:24:41+00:00April 6th, 2022|Fierce Pharma|
Folx Health doubles down on LGBT+ fund, focuses on Black trans communitynews2022-04-06T11:59:28+00:00April 6th, 2022|Fierce Pharma|
Salix: Half of IBS, chronic constipation patients lately find their condition ‘more challenging to manage’news2022-04-06T11:22:21+00:00April 6th, 2022|Fierce Pharma|
Could text messages nudge people toward COVID vaccines? Not here, but it might be bad timingnews2022-04-06T08:48:10+00:00April 6th, 2022|Fierce Pharma|
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant takes holdnews2022-04-05T19:30:26+00:00April 5th, 2022|Fierce Pharma|
BioNTech CEO’s pay fell last year, but he’s still a billionaire thanks to holdings in mRNA specialistnews2022-04-05T15:24:23+00:00April 5th, 2022|Fierce Pharma|
Merck, during a transition year, doled out nearly $30M to its pair of CEOsnews2022-04-05T15:15:01+00:00April 5th, 2022|Fierce Pharma|
GAO confirms questionable Trump-era celeb campaign ad spendnews2022-04-05T15:08:47+00:00April 5th, 2022|Fierce Pharma|
